Shanghai - Delayed Quote CNY

LBX Pharmacy Chain Joint Stock Company (603883.SS)

20.17
-0.20
(-0.98%)
At close: 3:00:04 PM GMT+8

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.
NameTitlePayExercisedYear Born
Ms. Li Wang President -- -- 1982
Mr. Lishan Chen CFO & Head of Finance -- -- 1979
Mr. Xin Wan Vice President -- -- 1984
Ms. Shini Feng Board Secretary -- -- 1985
Mr. Shiyong Su Vice President -- -- 1975
Mr. Yufei Jiang Vice President -- -- 1992
Mr. Wenshuai Zhang Vice President -- -- 1986
Ms. Xian Dang Vice President -- -- 1982
Ms. Huan Lin Vice President -- -- 1983
Shi Lei Head of Accounting -- -- --

LBX Pharmacy Chain Joint Stock Company

No. 808, Qingzhuhu Road
Kaifu District
Changsha, 410152
China
86 731 8403 5189 https://www.lbxdrugs.com
Sector: 
Healthcare
Full Time Employees: 
40,132

Description

LBX Pharmacy Chain Joint Stock Company operates a chain of pharmacy stores in Mainland China. The company operates through three segments: Retail business, Wholesale business, and Other. It engages in commodity retail and wholesale business; and pharmaceutical manufacturing business and others, as well as sells drugs, and other health and beauty-related products through its marketing network. The company is also involved in wholesale and retail of pharmaceutical products; Chinese medicine research and development; E-commerce; food and department store retail; commodity wholesale; and retail of maternal and infant products. In addition, it provides business, information technology consulting, technical, pharmaceutical consulting, clinic, and medical services. The company was formerly known as Laobaixing Pharmacy Chain Joint Stock Company. LBX Pharmacy Chain Joint Stock Company was founded in 2001 and is headquartered in Changsha, China.

Corporate Governance

LBX Pharmacy Chain Joint Stock Company’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

October 10, 2024 at 12:00 AM UTC

Ex-Dividend Date